These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24639805)

  • 1. The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial.
    Nadjarzadeh A; Dehghani Firouzabadi R; Vaziri N; Daneshbodi H; Lotfi MH; Mozaffari-Khosravi H
    Iran J Reprod Med; 2013 Aug; 11(8):665-72. PubMed ID: 24639805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
    Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.
    Al Kindi MK; Al Essry FS; Al Essry FS; Mula-Abed WA
    Oman Med J; 2012 Nov; 27(6):471-4. PubMed ID: 23226817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
    Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
    Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.
    Hajishafiee M; Askari G; Iranj B; Ghiasvand R; Bellissimo N; Totosy de Zepetnek J; Salehi-Abargouei A
    Horm Metab Res; 2016 May; 48(5):281-9. PubMed ID: 27077458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
    Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
    Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted article: The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Amini M; Bahmani F; Foroozanfard F; Vahedpoor Z; Ghaderi A; Taghizadeh M; Karbassizadeh H; Asemi Z
    J Psychosom Obstet Gynaecol; 2024 Dec; 45(1):1508282. PubMed ID: 30230402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual Disorders and Androgen-Related Traits in Young Women with Type 1 Diabetes Mellitus: a Clinical Study.
    Paschou SA; Vryonidou A; Melissourgou M; Kosteria I; Goulis D; Chrousos GP; Kanaka-Gantenbein C
    Endocr Pract; 2020 Nov; 26(11):1269-1276. PubMed ID: 33471656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
    Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
    Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
    J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.